ChemoCentryx
CCXI
#3719
Rank
NZ$6.40 B
Marketcap
NZ$89.10
Share price
0.00%
Change (1 day)
38.39%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.24. In 2021 the company made an earnings per share (EPS) of NZ-$3.24 a decrease over its 2020 EPS that were of NZ-$1.39.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-13.2%
2021NZ-$3.24133.33%
2020NZ-$1.39-16.49%
2019NZ-$1.6627.63%
2018NZ-$1.30-305.41%
2017NZ$0.63-142.53%
2016NZ-$1.49-19.44%
2015NZ-$1.85-0%
2014NZ-$1.8513.68%
2013NZ-$1.63-16.67%
2012NZ-$1.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97-562.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.24-169.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.52-208.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.81-866.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.02-594.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.10-288.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.10-288.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.66-305.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.35-172.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel